316 Synthetic Biology Applications I: Human Health and Disease


Description:
Synthetic Biology is built on the concept of interchangeable parts that can be pieced together to facilitate devices and organisms with new functions. As the breadth and sophistication of the underlying biological parts and the toolkits used to build them expand, so has the potential for more impactful applications. In this session, we will highlight applications in advanced by synthetic biology, including chemical synthesis, biomedical technology, and other creative avenues for which synthetic biology offers a unique solution to a relevant societal problem. Speakers from both academia and industry are encouraged to present in this session.

Sponsor:
Bioengineering


Chair:
Ian Wheeldon
UC Riverside
Chemical and Environmental Engineering
B319 Bourns Hall
Riverside, CA
92521
Email: iwheeldon@engr.ucr.edu

Co-Chair:
Keith E.J. Tyo
Assistant Professor
Northwestern University
Chemical & Biological Engineering
Evanston, IL
60208
Email: k-tyo@northwestern.edu


Papers:
Metabolic Engineering and Synthetic Biology with Human Milk Oligosaccharides
Fatima Enam, Iowa State University; Yanfen Bai, Iowa State University; Thomas J. Mansell, Iowa State University
Engineered Probiotics for the Treatment of Multidrug Resistant E.coli
Brittany Forkus, University of Minnesota; James Johnson, Minneapolis Veteran's Affairs Medical Center; Yiannis Kaznessis, University of Minnesota
Synthetic RNA-Inhibitor Antibiotics in Non-Traditional Antibiotic Pathways to Treat Multi-Drug Resistant Bacteria
Colleen Courtney, University of Colorado Boulder; Anushree Chatterjee, University of Colorado Boulder
Optogenetic Regulation of Insulin Secretion in Pancreatic Beta-Cells
Fan Zhang, Tufts University; Emmanuel S. Tzanakakis, Tufts University
An Oncogene Activity-Dependent “Suicide Gene” Vector System for Selective Targeting of Cancer Cells
Evan K. Day, University of Virginia; Ashley E. Pandolf, University of Virginia; Matthew J. Lazzara, University of Virginia
Genetically Encoded, Synthetic Glycopolymers for Tunable Control of Plasma Membrane Shapes and Organelle Biogenesis
Carolyn Shurer, Cornell University; Marshall Colville, Cornell University; Joe C-H. Kuo, Cornell University; LaDeidra Roberts, Cornell University; Hao Pan, Cornell University; Jay Gandhi, Cornell University; Matthew Paszek, Cornell University
Abstract Submissions Closed
See more of this Group/Topical: Food, Pharmaceutical & Bioengineering Division